Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-05-11 4:06 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | EcoR1 Capital LLC | 3,579,377 8.5% | 3,579,377 (New Position) | View |
| 2021-02-17 5:08 pm Purchase | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 8,053,298 21.98% | 1,285,714 (+19.00%) | View |
| 2021-02-12 9:18 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | MILLER RICHARD A MD | 2,179,559 7.5% | 220,417 (+11.25%) | View |
| 2021-02-12 4:09 pm Sale | 13G | CORVUS PHARMACEUTICALS INC CRVS | BIOTECHNOLOGY VALUE FUND L P | 2,898,797 9.99% | -22,380 (-0.77%) | View |
| 2020-07-09 4:29 pm Sale | 13D | CORVUS PHARMACEUTICALS INC CRVS | Novo Holdings A/S | 1,389,498 4.97% | -1,538,062 (-52.54%) | View |
| 2020-04-17 4:13 pm Purchase | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 6,767,584 24.2% | 142,656 (+2.15%) | View |
| 2020-02-18 4:35 pm Sale | 13G | CORVUS PHARMACEUTICALS INC CRVS | BIOTECHNOLOGY VALUE FUND L P | 2,921,177 9.9% | -161,820 (-5.25%) | View |
| 2020-02-14 2:52 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | BIOTECHNOLOGY VALUE FUND L P | 3,082,997 9.9% | 50,147 (+1.65%) | View |
| 2020-02-14 1:30 pm Sale | 13G | CORVUS PHARMACEUTICALS INC CRVS | PRICE T ROWE ASSOCIATES INC | 647,174 2.2% | -1,338,989 (-67.42%) | View |
| 2020-02-12 4:07 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | MILLER RICHARD A MD | 1,959,142 6.49% | 196,803 (+11.17%) | View |
| 2019-08-07 4:56 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | BIOTECHNOLOGY VALUE FUND L P | 3,032,850 10.3% | 1,142,343 (+60.43%) | View |
| 2019-07-29 4:38 pm Sale | 13D | CORVUS PHARMACEUTICALS INC CRVS | Novo Holdings A/S | 2,927,560 9.98% | -1,492,956 (-33.77%) | View |
| 2019-07-02 4:22 pm Purchase | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 6,624,928 22.6% | 657,344 (+11.02%) | View |